Choice of Host Cell Line Is Essential for the Functional Glycosylation of the Fc Region of Human IgG1 Inhibitors of Influenza B Viruses
Open Access
- 15 February 2020
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 204 (4) , 1022-1034
Abstract
Abs are glycoproteins that carry a conserved N-linked carbohydrate attached to the Fc whose presence and fine structure profoundly impacts on their in vivo immunogenicity, pharmacokinetics, and functional attributes. The host cell line used to produce IgG plays a major role in this glycosylation, as different systems express different glycosylation enzymes and transporters that contribute to the specificity and heterogeneity of the final IgG-Fc glycosylation profile. In this study, we compare two panels of glycan-adapted IgG1-Fc mutants expressed in either the human endothelial kidney 293-F or Chinese hamster ovary–K1 systems. We show that the types of N-linked glycans between matched pairs of Fc mutants vary greatly and in particular, with respect, to sialylation. These cell line effects on glycosylation profoundly influence the ability of the engineered Fcs to interact with either human or pathogen receptors. For example, we describe Fc mutants that potently disrupted influenza B–mediated agglutination of human erythrocytes when expressed in Chinese hamster ovary–K1, but not in human endothelial kidney 293-F cells. Key Points Choice of cell line is critical for functional glycosylation of human IgG1-Fc. Sialylated IgG1-Fc monomers block influenza B only when made by CHO-K1 cells.Keywords
All Related Versions
This publication has 61 references indexed in Scilit:
- Engineering Hydrophobic Protein–Carbohydrate Interactions to Fine-Tune Monoclonal AntibodiesJournal of the American Chemical Society, 2013
- Competition between Core-2 GlcNAc-transferase and ST6GalNAc-transferase Regulates the Synthesis of the Leukocyte Selectin Ligand on Human P-selectin Glycoprotein Ligand-1Journal of Biological Chemistry, 2013
- Dissecting the Molecular Mechanism of IVIg Therapy: The Interaction between Serum IgG and DC-SIGN is Independent of Antibody Glycoform or Fc DomainJournal of Molecular Biology, 2013
- Fc‐fusion proteins: new developments and future perspectivesEMBO Molecular Medicine, 2012
- Polymeric human Fc-fusion proteins with modified effector functionsScientific Reports, 2011
- Glycosylation of mouse and human immune cells: insights emerging from N-glycomics analysesBiochemical Society Transactions, 2011
- Implications of the presence of N-glycolylneuraminic acid in recombinant therapeutic glycoproteinsNature Biotechnology, 2010
- Glycomics Profiling of Chinese Hamster Ovary Cell Glycosylation Mutants Reveals N-Glycans of a Novel Size and ComplexityJournal of Biological Chemistry, 2010
- Identification of a receptor required for the anti-inflammatory activity of IVIGProceedings of the National Academy of Sciences, 2008
- Recapitulation of IVIG Anti-Inflammatory Activity with a Recombinant IgG FcScience, 2008